Injectable hydrogel therapies and their delivery strategies for treating myocardial infarction.
about
Emerging Implications for Extracellular Matrix-Based Technologies in Vascularized Composite AllotransplantationEnhancing retention and efficacy of cardiosphere-derived cells administered after myocardial infarction using a hyaluronan-gelatin hydrogelRegenerative Medicine Strategies for Esophageal RepairComparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heartSafety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction.Injectable graphene oxide/hydrogel-based angiogenic gene delivery system for vasculogenesis and cardiac repair.Concise review: injectable biomaterials for the treatment of myocardial infarction and peripheral artery disease: translational challenges and progress.Targeted injection of a biocomposite material alters macrophage and fibroblast phenotype and function following myocardial infarction: relation to left ventricular remodelingInjectable ECM scaffolds for cardiac repairAnisotropic silk biomaterials containing cardiac extracellular matrix for cardiac tissue engineering.Micro- and Nanoparticles for Treating Cardiovascular Disease.Quantification of decellularized human myocardial matrix: A comparison of six patientsIntramyocardial injection of hydrogel with high interstitial spread does not impact action potential propagationEnhanced infarct myocardium repair mediated by thermosensitive copolymer hydrogel-based stem cell transplantationPersonalised computational cardiology: Patient-specific modelling in cardiac mechanics and biomaterial injection therapies for myocardial infarction.Materials science and tissue engineering: repairing the heart.Injectable Hydrogels for Cardiac Tissue Repair after Myocardial InfarctionControlled release of TGF-beta 1 from RADA self-assembling peptide hydrogel scaffolds.PEG-maleimide hydrogels for protein and cell delivery in regenerative medicine.Biomimetic materials design for cardiac tissue regeneration.Cardiac tissue engineering: renewing the arsenal for the battle against heart disease.The Therapeutic Effect of Cell Transplantation Versus Noncellular Biomaterial Implantation on Cardiac Structure and Function Following Myocardial Infarction.Biomaterial-based scaffolds--current status and future directions.Biologic scaffolds for regenerative medicine: mechanisms of in vivo remodeling.Developing injectable nanomaterials to repair the heartAdvanced Strategies for End-Stage Heart Failure: Combining Regenerative Approaches with LVAD, a New Horizon?Decellularized myocardial matrix hydrogels: In basic research and preclinical studies.Optimizing the host substrate environment for cardiac angiogenesis, arteriogenesis, and myogenesis.Striated muscle function, regeneration, and repairMaintenance of HL-1 cardiomyocyte functional activity in PEGylated fibrin gels.Delivery of growth factor-based therapeutics in vascular diseases: Challenges and strategies.Circulating Biomarkers to Identify Responders in Cardiac Cell therapy.Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis.Enzymatically crosslinked gelatin hydrogel promotes the proliferation of adipose tissue-derived stromal cells.Enzyme-Responsive Nanoparticles for Targeted Accumulation and Prolonged Retention in Heart Tissue after Myocardial InfarctionArtificial Cardiac Muscle with or without the Use of Scaffolds.Design of Injectable Materials to Improve Stem Cell Transplantation.Remotely Activated Mechanotransduction via Magnetic Nanoparticles Promotes Mineralization Synergistically With Bone Morphogenetic Protein 2: Applications for Injectable Cell Therapy.Designing Acellular Injectable Biomaterial Therapeutics for Treating Myocardial Infarction and Peripheral Artery Disease.An in vitro investigation to assess procedure parameters for injecting therapeutic hydrogels into the myocardium.
P2860
Q26770126-4A783CFA-FD6B-4F12-A1EE-CCBFBB25E50CQ27002606-E46CEAA1-149F-4646-BC03-31FA7203B2CAQ27027551-B99D2A20-F9B5-45BD-8BB6-CF9443D2DA39Q33734834-5BBCB7F9-C3D4-4F1F-9E54-2D5B38645EC0Q34035670-9CC08CA1-AAF5-4FD8-8968-4B74AD5C8E04Q34104323-39DAA0D7-7906-41DA-B328-D28B5041E21EQ34109419-86F9363E-3940-4DA5-8105-691372343D48Q34125089-F4696C50-5307-4CA1-84D4-CAD80720D5FAQ35219353-477BFF13-0F0B-4B17-9B59-A34F69713A02Q35562754-285CAA02-AC9F-4C5A-81B1-8032CF65842FQ35801354-F469D2EE-7376-4D0E-BE26-D5A988CC308CQ36436938-54655A17-EF4A-42AB-8FC4-276855F84174Q36635288-C192230F-711F-4F22-B8B8-A03FB7A871B9Q37071171-23CE2740-5F82-4828-B1A5-D5B1E1EE12EEQ37143579-2AC0F191-096E-4667-94BD-E9C9EAAC472FQ37206811-F58BA622-0081-4D90-A72A-2BF84233B89AQ37275869-94A21B2D-2683-4008-9B5A-4F280F1CDBBBQ37283367-76BFF706-3665-44C4-9DF7-0A1B543A3BE1Q38123690-29567834-9CE3-4726-BB18-91CD1BBAFCD5Q38152417-F95089C9-19B5-4DE4-AE4A-78183EEBE07FQ38172390-E96ECF8B-EBB8-49A7-B4FA-38935E661AAAQ38177694-F8539C51-4566-4F73-98E2-6EF471DF87ADQ38199519-0B4889C2-D01D-4AA8-8CA9-71A969B78D28Q38248475-4CEDB1DA-D7B9-4021-B1A8-1645F3EDDEB3Q38416005-9C86EB8B-150F-432F-9476-0C9A8F01C7A2Q38437316-A8BFE5EE-8B7A-4EAC-9088-78AFE26C26B3Q38521799-377C6613-C711-4BA9-8468-238A8330A0CAQ38748690-12C27E1F-12EC-4E1E-9B5F-869610804B81Q38857890-3755C329-5094-4901-9F63-A2277E0B3F1CQ38912392-409F91CB-DDED-4D02-95A1-0ECB03AE6C54Q39179993-6B5CA321-BF7C-43F5-A165-65C499D11DB0Q40138868-126204E4-917D-4972-B5D7-778A85DD7647Q40183412-8740495A-A124-44E1-9EC0-9F907139DFE1Q41265256-4F919EED-D7F6-4416-9E20-E851AB9DE439Q41295473-F58AB93C-7136-4702-A3FC-E48AD9958C5AQ41509582-1CC3BA71-D5E8-4FF9-B40B-7BA1BD96C721Q41560335-A422FFCB-669D-4BA0-AED8-22BC4917C015Q41840313-9A60E409-77E3-490B-8331-C28223663CDFQ46813976-FABD496D-D958-4442-B70C-D4DD7FA46994Q48965797-CBE066F6-ECE0-43BD-9F5A-E5F7BE0DC986
P2860
Injectable hydrogel therapies and their delivery strategies for treating myocardial infarction.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Injectable hydrogel therapies ...... reating myocardial infarction.
@en
type
label
Injectable hydrogel therapies ...... reating myocardial infarction.
@en
prefLabel
Injectable hydrogel therapies ...... reating myocardial infarction.
@en
P2860
P1476
Injectable hydrogel therapies ...... reating myocardial infarction.
@en
P2093
Karen L Christman
Todd D Johnson
P2860
P356
10.1517/17425247.2013.739156
P407
P577
2012-11-09T00:00:00Z